Shimada, Hitoshi

Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls

Maruyama, M., Shimada, H., Suhara, T., Shinotoh, H., Ji, B., Maeda, J., Zhang, M.-R., Trojanowski, J. Q., Lee, V. M.-Y., Ono, M., et al. (2013) · Neuron

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 760

Apathy correlates with prefrontal amyloid deposition in Alzheimer's disease

Mori, T., Shimada, H., Shinotoh, H., Hirano, S., Eguchi, Y., Yamada, M., Fukuhara, R., Tanimukai, S., Zhang, M.-R., Kuwabara, S., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 122

In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: A PET and MRI study

Miyoshi, M., Shinotoh, H., Wszolek, Z. K., Strongosky, A. J., Shimada, H., Arakawa, R., Higuchi, M., Ikoma, Y., Yasuno, F., Fukushi, K., et al. (2010) · Parkinsonism & Related Disorders

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 75

In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease

Terada, T., Yokokura, M., Obi, T., Bunai, T., Yoshikawa, E., Ando, I., Shimada, H., Suhara, T., Higuchi, M., & Ouchi, Y. (2019) · Journal of Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 60

Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2

Moriguchi, S., Takano, H., Kimura, Y., Nagashima, T., Takahata, K., Kubota, M., Kitamura, S., Ishii, T., Ichise, M., Zhang, M.-R., et al. (2017) · International Journal of Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 47

Dementia with Lewy bodies can be well‐differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity—a [11C]MP4A PET study

Shimada, H., Hirano, S., Sinotoh, H., Ota, T., Tanaka, N., Sato, K., Yamada, M., Fukushi, K., Irie, T., Zhang, M. R., et al. (2015) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 40

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features

Ikeda, A., Shimada, H., Nishioka, K., Takanashi, M., Hayashida, A., Li, Y., Yoshino, H., Funayama, M., Ueno, Y., Hatano, T., et al. (2019) · Movement Disorders

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 22

Effects of food on the pharmacokinetics of omega-3-carboxylic acids in healthy Japanese male subjects: A phase I, randomized, open-label, three-period, crossover trial

Shimada, H., Nilsson, C., Noda, Y., Kim, H., Lundström, T., & Yajima, T. (2017) · Journal of Atherosclerosis and Thrombosis

Fatty Acid Research and HealthAquaculture Nutrition and Growth

Cited by 12